Modular nucleic acid assembled p/MHC microarrays for multiplexed sorting of antigen-specific T cells.

The human immune system consists of a large number of T cells capable of recognizing and responding to antigens derived from various sources. The development of peptide-major histocompatibility (p/MHC) tetrameric complexes has enabled the direct detection of these antigen-specific T cells. With the goal of increasing throughput and multiplexing of T cell detection, protein microarrays spotted with defined p/MHC complexes have been reported, but studies have been limited due to the inherent instability and reproducibility of arrays produced via conventional spotted methods. Herein, we report on a platform for the detection of antigen-specific T cells on glass substrates that offers significant advantages over existing surface-bound schemes. In this approach, called "Nucleic Acid Cell Sorting (NACS)", single-stranded DNA oligomers conjugated site-specifically to p/MHC tetramers are employed to immobilize p/MHC tetramers via hybridization to a complementary-printed substrate. Fully assembled p/MHC arrays are used to detect and enumerate T cells captured from cellular suspensions, including primary human T cells collected from cancer patients. NACS arrays outperform conventional spotted arrays assessed in key criteria such as repeatability and homogeneity. The versatility of employing DNA sequences for cell sorting is exploited to enable the programmed, selective release of target populations of immobilized T cells with restriction endonucleases for downstream analysis. Because of the performance, facile and modular assembly of p/MHC tetramer arrays, NACS holds promise as a versatile platform for multiplexed T cell detection.

[1]  Gabriel A Kwong,et al.  DNA-encoded antibody libraries: a unified platform for multiplexed cell sorting and detection of genes and proteins. , 2007, Journal of the American Chemical Society.

[2]  Marion Pepper,et al.  Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. , 2007, Immunity.

[3]  C. Cantor,et al.  Expression of a cloned streptavidin gene in Escherichia coli. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Butler,et al.  The physical and functional behavior of capture antibodies adsorbed on polystyrene. , 1992, Journal of immunological methods.

[5]  J. Wargo,et al.  Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression , 2009, Cancer Immunology, Immunotherapy.

[6]  M. Davis,et al.  Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Smaroula Dilioglou,et al.  Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide–based retroviral vector , 2004, Nature Biotechnology.

[8]  Jonathan P Schneck,et al.  Detection of antigen‐specific T cells on p/MHC microarrays , 2007, Journal of molecular recognition : JMR.

[9]  P. Brown,et al.  Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions , 2001, Genome Biology.

[10]  S. Rosenberg,et al.  A new era for cancer immunotherapy based on the genes that encode cancer antigens. , 1999, Immunity.

[11]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[12]  Richard A Mathies,et al.  Programmable cell adhesion encoded by DNA hybridization. , 2006, Angewandte Chemie.

[13]  W. Lam,et al.  DNA-coated AFM cantilevers for the investigation of cell adhesion and the patterning of live cells. , 2008, Angewandte Chemie.

[14]  N. Green [74] Spectrophotometric determination of avidin and biotin , 1970 .

[15]  M. Raffeld,et al.  Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.

[16]  Jianhong Cao,et al.  Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. , 2008, The New England journal of medicine.

[17]  Hidde L. Ploegh,et al.  Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers , 2008, Proceedings of the National Academy of Sciences.

[18]  D. Wiley,et al.  HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Steven A. Rosenberg,et al.  Progress in human tumour immunology and immunotherapy , 2001, Nature.

[20]  A. Casrouge,et al.  A Direct Estimate of the Human αβ T Cell Receptor Diversity , 1999 .

[21]  D. Price,et al.  Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry , 2006, Nature Medicine.

[22]  A. Mirzabekov,et al.  Protein microchips: use for immunoassay and enzymatic reactions. , 2000, Analytical biochemistry.

[23]  T. Schumacher,et al.  Design and use of conditional MHC class I ligands , 2006, Nature Medicine.

[24]  Shaoyi Jiang,et al.  DNA-directed protein immobilization for simultaneous detection of multiple analytes by surface plasmon resonance biosensor. , 2006, Analytical chemistry.

[25]  J. Stone,et al.  HLA-restricted epitope identification and detection of functional T cell responses by using MHC-peptide and costimulatory microarrays. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Sékaly,et al.  Cutting Edge: Detection of Antigen-Specific CD4+ T Cells by HLA-DR1 Oligomers Is Dependent on the T Cell Activation State1 , 2001, The Journal of Immunology.

[27]  S. Rosenberg,et al.  MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte. , 1999, Cancer research.

[28]  C. Cantor,et al.  A streptavidin mutant useful for directed immobilization on solid surfaces. , 2001, Bioconjugate chemistry.

[29]  P. Peluso,et al.  Optimizing antibody immobilization strategies for the construction of protein microarrays. , 2003, Analytical biochemistry.

[30]  S. Rosenberg,et al.  Gene Transfer of Tumor-Reactive TCR Confers Both High Avidity and Tumor Reactivity to Nonreactive Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes1 , 2006, The Journal of Immunology.

[31]  L. Hood,et al.  Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood , 2008, Nature Biotechnology.

[32]  C. Niemeyer Functional devices from DNA and proteins , 2007 .

[33]  Milan Mrksich,et al.  Antibody arrays prepared by cutinase-mediated immobilization on self-assembled monolayers. , 2004, Analytical chemistry.

[34]  T. Schumacher,et al.  Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7 , 2008, Proceedings of the National Academy of Sciences.

[35]  Martin Saunders,et al.  Two helium atoms inside fullerenes: probing the internal magnetic field in C60(6-) and C70(6-). , 2002, Journal of the American Chemical Society.

[36]  I. Hamachi,et al.  Semi-wet peptide/protein array using supramolecular hydrogel , 2004, Nature materials.

[37]  E. Voss,et al.  The immunochemistry of sandwich ELISAs--VI. Greater than 90% of monoclonal and 75% of polyclonal anti-fluorescyl capture antibodies (CAbs) are denatured by passive adsorption. , 1993, Molecular immunology.

[38]  T. Schumacher,et al.  T-cell-receptor gene therapy , 2002, Nature Reviews Immunology.

[39]  S. Rosenberg,et al.  Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes , 2006, Science.

[40]  J. Altman,et al.  A robust method for production of MHC tetramers with small molecule fluorophores. , 2007, Journal of immunological methods.

[41]  S. Schreiber,et al.  Printing proteins as microarrays for high-throughput function determination. , 2000, Science.